Item 8.    Financial Statements and Supplementary Data
  
  

> **Index to Consolidated Financial Statements**
>
> Index to Consolidated Financial Statements / Index to Consolidated Financial Statements / Page / Page / Page
>
> Consolidated Statements of Operations for the years ended September 27, 2025, September 28, 2024 and September 30, 2023 ... Consolidated Statements of Operations for the years ended September 27, 2025, September 28, 2024 and September 30, 2023 / Consolidated Statements of Operations for the years ended September 27, 2025, September 28, 2024 and September 30, 2023 / 29 / 29 / 29
> Consolidated Statements of Comprehensive Income for the years ended September 27, 2025, September 28, 2024 and September 30, 2023 ... Consolidated Statements of Comprehensive Income for the years ended September 27, 2025, September 28, 2024 and September 30, 2023 / Consolidated Statements of Comprehensive Income for the years ended September 27, 2025, September 28, 2024 and September 30, 2023 / 30 / 30 / 30
> Consolidated Balance Sheets as of September 27, 2025 and September 28, 2024 ... Consolidated Balance Sheets as of September 27, 2025 and September 28, 2024 / Consolidated Balance Sheets as of September 27, 2025 and September 28, 2024 / 31 / 31 / 31
> Consolidated Statements of Shareholders’ Equity for the years ended September 27, 2025, September 28, 2024 and September 30, 2023 ... Consolidated Statements of Shareholders’ Equity for the years ended September 27, 2025, September 28, 2024 and September 30, 2023 / Consolidated Statements of Shareholders’ Equity for the years ended September 27, 2025, September 28, 2024 and September 30, 2023 / 32 / 32 / 32
> Consolidated Statements of Cash Flows for the years ended September 27, 2025, September 28, 2024 and September 30, 2023 ... Consolidated Statements of Cash Flows for the years ended September 27, 2025, September 28, 2024 and September 30, 2023 / Consolidated Statements of Cash Flows for the years ended September 27, 2025, September 28, 2024 and September 30, 2023 / 33 / 33 / 33
> Notes to Consolidated Financial Statements ... Notes to Consolidated Financial Statements / Notes to Consolidated Financial Statements / 34 / 34 / 34
> Reports of Independent Registered Public Accounting Firm ... Reports of Independent Registered Public Accounting Firm / Reports of Independent Registered Public Accounting Firm / 49 / 49 / 49

  All financial statement schedules have been omitted, since the required information is not applicable or is not present in amounts sufficient to require submission of the schedule, or because the information required is included in the consolidated financial statements and accompanying notes.
    Apple Inc. | 2025 Form 10-K | 28

  

---

  
  

  Apple Inc.
  CONSOLIDATED STATEMENTS OF OPERATIONS
  (In millions, except number of shares, which are reflected in thousands, and per-share amounts)
  
  
  

> **Years ended**
>
> Years ended / Years ended / Years ended / Years ended / Years ended / Years ended / Years ended / Years ended / Years ended / Years ended / Years ended / Years ended / Years ended / Years ended
>
> September 27,2025 / September 27,2025 / September 27,2025 / September 28,2024 / September 28,2024 / September 28,2024 / September 30,2023 / September 30,2023 / September 30,2023
> Net sales: .............................. Net sales: / Net sales:
> Products ................................ Products / Products / $ / 307,003 / $ / 294,866 / $ / 298,085
> Services ................................ Services / Services / 109,158 / 109,158 / 96,169 / 96,169 / 85,200 / 85,200
> Total net sales ......................... Total net sales / Total net sales / 416,161 / 416,161 / 391,035 / 391,035 / 383,285 / 383,285
> Cost of sales: .......................... Cost of sales: / Cost of sales:
> Products ................................ Products / Products / 194,116 / 194,116 / 185,233 / 185,233 / 189,282 / 189,282
> Services ................................ Services / Services / 26,844 / 26,844 / 25,119 / 25,119 / 24,855 / 24,855
> Total cost of sales ..................... Total cost of sales / Total cost of sales / 220,960 / 220,960 / 210,352 / 210,352 / 214,137 / 214,137
> Gross margin ............................ Gross margin / Gross margin / 195,201 / 195,201 / 180,683 / 180,683 / 169,148 / 169,148
> Operating expenses: ..................... Operating expenses: / Operating expenses:
> Research and development ................ Research and development / Research and development / 34,550 / 34,550 / 31,370 / 31,370 / 29,915 / 29,915
> Selling, general and administrative ..... Selling, general and administrative / Selling, general and administrative / 27,601 / 27,601 / 26,097 / 26,097 / 24,932 / 24,932
> Total operating expenses ................ Total operating expenses / Total operating expenses / 62,151 / 62,151 / 57,467 / 57,467 / 54,847 / 54,847
> Operating income ........................ Operating income / Operating income / 133,050 / 133,050 / 123,216 / 123,216 / 114,301 / 114,301
> Other income/(expense), net ............. Other income/(expense), net / Other income/(expense), net / (321) / (321) / 269 / 269 / (565) / (565)
> Income before provision for income taxes ... Income before provision for income taxes / Income before provision for income taxes / 132,729 / 132,729 / 123,485 / 123,485 / 113,736 / 113,736
> Provision for income taxes .............. Provision for income taxes / Provision for income taxes / 20,719 / 20,719 / 29,749 / 29,749 / 16,741 / 16,741
> Net income .............................. Net income / Net income / $ / 112,010 / $ / 93,736 / $ / 96,995
> Earnings per share: ..................... Earnings per share: / Earnings per share:
> Basic ................................... Basic / Basic / $ / 7.49 / $ / 6.11 / $ / 6.16
> Diluted ................................. Diluted / Diluted / $ / 7.46 / $ / 6.08 / $ / 6.13
> Shares used in computing earnings per share: ... Shares used in computing earnings per share: / Shares used in computing earnings per share:
> Basic ................................... Basic / Basic / 14,948,500 / 14,948,500 / 15,343,783 / 15,343,783 / 15,744,231 / 15,744,231
> Diluted ................................. Diluted / Diluted / 15,004,697 / 15,004,697 / 15,408,095 / 15,408,095 / 15,812,547 / 15,812,547

  See accompanying Notes to Consolidated Financial Statements.
    Apple Inc. | 2025 Form 10-K | 29

  

---

  
  

  Apple Inc.
  CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
  (In millions)
  
  
  

> **Years ended**
>
> Years ended / Years ended / Years ended / Years ended / Years ended / Years ended / Years ended / Years ended / Years ended / Years ended / Years ended / Years ended / Years ended / Years ended
>
> September 27,2025 / September 27,2025 / September 27,2025 / September 28,2024 / September 28,2024 / September 28,2024 / September 30,2023 / September 30,2023 / September 30,2023
> Net income .............................. Net income / Net income / $ / 112,010 / $ / 93,736 / $ / 96,995
> Other comprehensive income/(loss): ...... Other comprehensive income/(loss): / Other comprehensive income/(loss):
> Change in foreign currency translation, net of tax ... Change in foreign currency translation, net of tax / Change in foreign currency translation, net of tax / (267) / (267) / 395 / 395 / (765) / (765)
> Change in unrealized gains/losses on derivative instruments, net of tax: ... Change in unrealized gains/losses on derivative instruments, net of tax: / Change in unrealized gains/losses on derivative instruments, net of tax:
> Change in fair value of derivative instruments ... Change in fair value of derivative instruments / Change in fair value of derivative instruments / 849 / 849 / (832) / (832) / 323 / 323
> Adjustment for net (gains)/losses realized and included in net income ... Adjustment for net (gains)/losses realized and included in net income / Adjustment for net (gains)/losses realized and included in net income / (212) / (212) / (1,337) / (1,337) / (1,717) / (1,717)
> Total change in unrealized gains/losses on derivative instruments ... Total change in unrealized gains/losses on derivative instruments / Total change in unrealized gains/losses on derivative instruments / 637 / 637 / (2,169) / (2,169) / (1,394) / (1,394)
> Change in unrealized gains/losses on marketable debt securities, net of tax: ... Change in unrealized gains/losses on marketable debt securities, net of tax: / Change in unrealized gains/losses on marketable debt securities, net of tax:
> Change in fair value of marketable debt securities ... Change in fair value of marketable debt securities / Change in fair value of marketable debt securities / 817 / 817 / 5,850 / 5,850 / 1,563 / 1,563
> Adjustment for net (gains)/losses realized and included in net income ... Adjustment for net (gains)/losses realized and included in net income / Adjustment for net (gains)/losses realized and included in net income / 414 / 414 / 204 / 204 / 253 / 253
> Total change in unrealized gains/losses on marketable debt securities ... Total change in unrealized gains/losses on marketable debt securities / Total change in unrealized gains/losses on marketable debt securities / 1,231 / 1,231 / 6,054 / 6,054 / 1,816 / 1,816
> Total other comprehensive income/(loss) ... Total other comprehensive income/(loss) / Total other comprehensive income/(loss) / 1,601 / 1,601 / 4,280 / 4,280 / (343) / (343)
> Total comprehensive income .............. Total comprehensive income / Total comprehensive income / $ / 113,611 / $ / 98,016 / $ / 96,652

  See accompanying Notes to Consolidated Financial Statements.
    Apple Inc. | 2025 Form 10-K | 30

  

---

  
  

  Apple Inc.
  CONSOLIDATED BALANCE SHEETS
  (In millions, except number of shares, which are reflected in thousands, and par value)
  
  
  

> **September 27,2025**
>
> September 27,2025 / September 27,2025 / September 28,2024 / September 28,2024 / September 28,2024
>
> ASSETS: ................................. ASSETS: / ASSETS: / ASSETS: / ASSETS: / ASSETS: / ASSETS: / ASSETS: / ASSETS: / ASSETS: / ASSETS: / ASSETS:
> Current assets: ......................... Current assets: / Current assets:
> Cash and cash equivalents ............... Cash and cash equivalents / Cash and cash equivalents / $ / 35,934 / $ / 29,943
> Marketable securities ................... Marketable securities / Marketable securities / 18,763 / 18,763 / 35,228 / 35,228
> Accounts receivable, net ................ Accounts receivable, net / Accounts receivable, net / 39,777 / 39,777 / 33,410 / 33,410
> Vendor non-trade receivables ............ Vendor non-trade receivables / Vendor non-trade receivables / 33,180 / 33,180 / 32,833 / 32,833
> Inventories ............................. Inventories / Inventories / 5,718 / 5,718 / 7,286 / 7,286
> Other current assets .................... Other current assets / Other current assets / 14,585 / 14,585 / 14,287 / 14,287
> Total current assets .................... Total current assets / Total current assets / 147,957 / 147,957 / 152,987 / 152,987
> Non-current assets: ..................... Non-current assets: / Non-current assets:
> Marketable securities ................... Marketable securities / Marketable securities / 77,723 / 77,723 / 91,479 / 91,479
> Property, plant and equipment, net ...... Property, plant and equipment, net / Property, plant and equipment, net / 49,834 / 49,834 / 45,680 / 45,680
> Other non-current assets ................ Other non-current assets / Other non-current assets / 83,727 / 83,727 / 74,834 / 74,834
> Total non-current assets ................ Total non-current assets / Total non-current assets / 211,284 / 211,284 / 211,993 / 211,993
> Total assets ............................ Total assets / Total assets / $ / 359,241 / $ / 364,980
> LIABILITIES AND SHAREHOLDERS’ EQUITY: ... LIABILITIES AND SHAREHOLDERS’ EQUITY: / LIABILITIES AND SHAREHOLDERS’ EQUITY: / LIABILITIES AND SHAREHOLDERS’ EQUITY: / LIABILITIES AND SHAREHOLDERS’ EQUITY: / LIABILITIES AND SHAREHOLDERS’ EQUITY: / LIABILITIES AND SHAREHOLDERS’ EQUITY: / LIABILITIES AND SHAREHOLDERS’ EQUITY: / LIABILITIES AND SHAREHOLDERS’ EQUITY: / LIABILITIES AND SHAREHOLDERS’ EQUITY: / LIABILITIES AND SHAREHOLDERS’ EQUITY: / LIABILITIES AND SHAREHOLDERS’ EQUITY:
> Current liabilities: .................... Current liabilities: / Current liabilities:
> Accounts payable ........................ Accounts payable / Accounts payable / $ / 69,860 / $ / 68,960
> Other current liabilities ............... Other current liabilities / Other current liabilities / 66,387 / 66,387 / 78,304 / 78,304
> Deferred revenue ........................ Deferred revenue / Deferred revenue / 9,055 / 9,055 / 8,249 / 8,249
> Commercial paper ........................ Commercial paper / Commercial paper / 7,979 / 7,979 / 9,967 / 9,967
> Term debt ............................... Term debt / Term debt / 12,350 / 12,350 / 10,912 / 10,912
> Total current liabilities ............... Total current liabilities / Total current liabilities / 165,631 / 165,631 / 176,392 / 176,392
> Non-current liabilities: ................ Non-current liabilities: / Non-current liabilities:
> Term debt ............................... Term debt / Term debt / 78,328 / 78,328 / 85,750 / 85,750
> Other non-current liabilities ........... Other non-current liabilities / Other non-current liabilities / 41,549 / 41,549 / 45,888 / 45,888
> Total non-current liabilities ........... Total non-current liabilities / Total non-current liabilities / 119,877 / 119,877 / 131,638 / 131,638
> Total liabilities ....................... Total liabilities / Total liabilities / 285,508 / 285,508 / 308,030 / 308,030
> Commitments and contingencies ........... Commitments and contingencies / Commitments and contingencies
> Shareholders’ equity: ................... Shareholders’ equity: / Shareholders’ equity:
> Common stock and additional paid-in capital, $0.00001 par value: 50,400,000 shares authorized; 14,773,260 and 15,116,786 shares issued and outstanding, respectively ... Common stock and additional paid-in capital, $0.00001 par value: 50,400,000 shares authorized; 14,773,260 and 15,116,786 shares issued and outstanding, respectively / Common stock and additional paid-in capital, $0.00001 par value: 50,400,000 shares authorized; 14,773,260 and 15,116,786 shares issued and outstanding, respectively / 93,568 / 93,568 / 83,276 / 83,276
> Accumulated deficit ..................... Accumulated deficit / Accumulated deficit / (14,264) / (14,264) / (19,154) / (19,154)
> Accumulated other comprehensive loss .... Accumulated other comprehensive loss / Accumulated other comprehensive loss / (5,571) / (5,571) / (7,172) / (7,172)
> Total shareholders’ equity .............. Total shareholders’ equity / Total shareholders’ equity / 73,733 / 73,733 / 56,950 / 56,950
> Total liabilities and shareholders’ equity ... Total liabilities and shareholders’ equity / Total liabilities and shareholders’ equity / $ / 359,241 / $ / 364,980

  See accompanying Notes to Consolidated Financial Statements.
    Apple Inc. | 2025 Form 10-K | 31

  

---

  
  

  Apple Inc.
  CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY
  (In millions, except per-share amounts)
  
  
  

> **Years ended**
>
> Years ended / Years ended / Years ended / Years ended / Years ended / Years ended / Years ended / Years ended / Years ended / Years ended / Years ended / Years ended / Years ended / Years ended
>
> September 27,2025 / September 27,2025 / September 27,2025 / September 28,2024 / September 28,2024 / September 28,2024 / September 30,2023 / September 30,2023 / September 30,2023
> Total shareholders’ equity, beginning balances ... Total shareholders’ equity, beginning balances / Total shareholders’ equity, beginning balances / $ / 56,950 / $ / 62,146 / $ / 50,672
> Common stock and additional paid-in capital: ... Common stock and additional paid-in capital: / Common stock and additional paid-in capital:
> Beginning balances ...................... Beginning balances / Beginning balances / 83,276 / 83,276 / 73,812 / 73,812 / 64,849 / 64,849
> Common stock issued ..................... Common stock issued / Common stock issued / 1,498 / 1,498 / 1,423 / 1,423 / 1,346 / 1,346
> Common stock withheld related to net share settlement of equity awards ... Common stock withheld related to net share settlement of equity awards / Common stock withheld related to net share settlement of equity awards / (4,452) / (4,452) / (3,993) / (3,993) / (3,521) / (3,521)
> Share-based compensation ................ Share-based compensation / Share-based compensation / 13,246 / 13,246 / 12,034 / 12,034 / 11,138 / 11,138
> Ending balances ......................... Ending balances / Ending balances / 93,568 / 93,568 / 83,276 / 83,276 / 73,812 / 73,812
> Accumulated deficit: .................... Accumulated deficit: / Accumulated deficit:
> Beginning balances ...................... Beginning balances / Beginning balances / (19,154) / (19,154) / (214) / (214) / (3,068) / (3,068)
> Net income .............................. Net income / Net income / 112,010 / 112,010 / 93,736 / 93,736 / 96,995 / 96,995
> Dividends and dividend equivalents declared ... Dividends and dividend equivalents declared / Dividends and dividend equivalents declared / (15,413) / (15,413) / (15,218) / (15,218) / (14,996) / (14,996)
> Common stock withheld related to net share settlement of equity awards ... Common stock withheld related to net share settlement of equity awards / Common stock withheld related to net share settlement of equity awards / (1,655) / (1,655) / (1,612) / (1,612) / (2,099) / (2,099)
> Common stock repurchased ................ Common stock repurchased / Common stock repurchased / (90,052) / (90,052) / (95,846) / (95,846) / (77,046) / (77,046)
> Ending balances ......................... Ending balances / Ending balances / (14,264) / (14,264) / (19,154) / (19,154) / (214) / (214)
> Accumulated other comprehensive loss: ... Accumulated other comprehensive loss: / Accumulated other comprehensive loss:
> Beginning balances ...................... Beginning balances / Beginning balances / (7,172) / (7,172) / (11,452) / (11,452) / (11,109) / (11,109)
> Other comprehensive income/(loss) ....... Other comprehensive income/(loss) / Other comprehensive income/(loss) / 1,601 / 1,601 / 4,280 / 4,280 / (343) / (343)
> Ending balances ......................... Ending balances / Ending balances / (5,571) / (5,571) / (7,172) / (7,172) / (11,452) / (11,452)
> Total shareholders’ equity, ending balances ... Total shareholders’ equity, ending balances / Total shareholders’ equity, ending balances / $ / 73,733 / $ / 56,950 / $ / 62,146
> Dividends and dividend equivalents declared per share or RSU ... Dividends and dividend equivalents declared per share or RSU / Dividends and dividend equivalents declared per share or RSU / $ / 1.02 / $ / 0.98 / $ / 0.94

  See accompanying Notes to Consolidated Financial Statements.
    Apple Inc. | 2025 Form 10-K | 32

  

---

  
  

  Apple Inc.
  CONSOLIDATED STATEMENTS OF CASH FLOWS
  (In millions)
  

> **Years ended**
>
> Years ended / Years ended / Years ended / Years ended / Years ended / Years ended / Years ended / Years ended / Years ended / Years ended / Years ended / Years ended / Years ended / Years ended
>
> September 27,2025 / September 27,2025 / September 27,2025 / September 28,2024 / September 28,2024 / September 28,2024 / September 30,2023 / September 30,2023 / September 30,2023
> Cash, cash equivalents, and restricted cash and cash equivalents, beginning balances ... Cash, cash equivalents, and restricted cash and cash equivalents, beginning balances / Cash, cash equivalents, and restricted cash and cash equivalents, beginning balances / $ / 29,943 / $ / 30,737 / $ / 24,977
> Operating activities: ................... Operating activities: / Operating activities:
> Net income .............................. Net income / Net income / 112,010 / 112,010 / 93,736 / 93,736 / 96,995 / 96,995
> Adjustments to reconcile net income to cash generated by operating activities: ... Adjustments to reconcile net income to cash generated by operating activities: / Adjustments to reconcile net income to cash generated by operating activities:
> Depreciation and amortization ........... Depreciation and amortization / Depreciation and amortization / 11,698 / 11,698 / 11,445 / 11,445 / 11,519 / 11,519
> Share-based compensation expense ........ Share-based compensation expense / Share-based compensation expense / 12,863 / 12,863 / 11,688 / 11,688 / 10,833 / 10,833
> Other ................................... Other / Other / (89) / (89) / (2,266) / (2,266) / (2,227) / (2,227)
> Changes in operating assets and liabilities: ... Changes in operating assets and liabilities: / Changes in operating assets and liabilities:
> Accounts receivable, net ................ Accounts receivable, net / Accounts receivable, net / (6,682) / (6,682) / (3,788) / (3,788) / (1,688) / (1,688)
> Vendor non-trade receivables ............ Vendor non-trade receivables / Vendor non-trade receivables / (347) / (347) / (1,356) / (1,356) / 1,271 / 1,271
> Inventories ............................. Inventories / Inventories / 1,400 / 1,400 / (1,046) / (1,046) / (1,618) / (1,618)
> Other current and non-current assets .... Other current and non-current assets / Other current and non-current assets / (9,197) / (9,197) / (11,731) / (11,731) / (5,684) / (5,684)
> Accounts payable ........................ Accounts payable / Accounts payable / 902 / 902 / 6,020 / 6,020 / (1,889) / (1,889)
> Other current and non-current liabilities ... Other current and non-current liabilities / Other current and non-current liabilities / (11,076) / (11,076) / 15,552 / 15,552 / 3,031 / 3,031
> Cash generated by operating activities ... Cash generated by operating activities / Cash generated by operating activities / 111,482 / 111,482 / 118,254 / 118,254 / 110,543 / 110,543
> Investing activities: ................... Investing activities: / Investing activities:
> Purchases of marketable securities ...... Purchases of marketable securities / Purchases of marketable securities / (24,407) / (24,407) / (48,656) / (48,656) / (29,513) / (29,513)
> Proceeds from maturities of marketable securities ... Proceeds from maturities of marketable securities / Proceeds from maturities of marketable securities / 40,907 / 40,907 / 51,211 / 51,211 / 39,686 / 39,686
> Proceeds from sales of marketable securities ... Proceeds from sales of marketable securities / Proceeds from sales of marketable securities / 12,890 / 12,890 / 11,135 / 11,135 / 5,828 / 5,828
> Payments for acquisition of property, plant and equipment ... Payments for acquisition of property, plant and equipment / Payments for acquisition of property, plant and equipment / (12,715) / (12,715) / (9,447) / (9,447) / (10,959) / (10,959)
> Other ................................... Other / Other / (1,480) / (1,480) / (1,308) / (1,308) / (1,337) / (1,337)
> Cash generated by investing activities ... Cash generated by investing activities / Cash generated by investing activities / 15,195 / 15,195 / 2,935 / 2,935 / 3,705 / 3,705
> Financing activities: ................... Financing activities: / Financing activities:
> Payments for taxes related to net share settlement of equity awards ... Payments for taxes related to net share settlement of equity awards / Payments for taxes related to net share settlement of equity awards / (5,960) / (5,960) / (5,441) / (5,441) / (5,431) / (5,431)
> Payments for dividends and dividend equivalents ... Payments for dividends and dividend equivalents / Payments for dividends and dividend equivalents / (15,421) / (15,421) / (15,234) / (15,234) / (15,025) / (15,025)
> Repurchases of common stock ............. Repurchases of common stock / Repurchases of common stock / (90,711) / (90,711) / (94,949) / (94,949) / (77,550) / (77,550)
> Proceeds from issuance of term debt, net ... Proceeds from issuance of term debt, net / Proceeds from issuance of term debt, net / 4,481 / 4,481 / — / — / 5,228 / 5,228
> Repayments of term debt ................. Repayments of term debt / Repayments of term debt / (10,932) / (10,932) / (9,958) / (9,958) / (11,151) / (11,151)
> Proceeds from/(Repayments of) commercial paper, net ... Proceeds from/(Repayments of) commercial paper, net / Proceeds from/(Repayments of) commercial paper, net / (2,032) / (2,032) / 3,960 / 3,960 / (3,978) / (3,978)
> Other ................................... Other / Other / (111) / (111) / (361) / (361) / (581) / (581)
> Cash used in financing activities ....... Cash used in financing activities / Cash used in financing activities / (120,686) / (120,686) / (121,983) / (121,983) / (108,488) / (108,488)
> Increase/(Decrease) in cash, cash equivalents, and restricted cash and cash equivalents ... Increase/(Decrease) in cash, cash equivalents, and restricted cash and cash equivalents / Increase/(Decrease) in cash, cash equivalents, and restricted cash and cash equivalents / 5,991 / 5,991 / (794) / (794) / 5,760 / 5,760
> Cash, cash equivalents, and restricted cash and cash equivalents, ending balances ... Cash, cash equivalents, and restricted cash and cash equivalents, ending balances / Cash, cash equivalents, and restricted cash and cash equivalents, ending balances / $ / 35,934 / $ / 29,943 / $ / 30,737
> Supplemental cash flow disclosure: ...... Supplemental cash flow disclosure: / Supplemental cash flow disclosure:
> Cash paid for income taxes, net ......... Cash paid for income taxes, net / Cash paid for income taxes, net / $ / 43,369 / $ / 26,102 / $ / 18,679

  See accompanying Notes to Consolidated Financial Statements.
    Apple Inc. | 2025 Form 10-K | 33

  

---

  
  

  Apple Inc.